A pilot study evaluating the effect of recombinant human bone morphogenetic protein-2 and recombinant human beta-nerve growth factor on the healing of class III furcation defects in dogs

Journal of Periodontology

Volumn 81, Issue 9, 2010, Pages 1289-1298

  Yan, Xiang Zhen ^a   Ge, Shao Hua ^a   Sun, Qin Feng ^a   Guo, Hong Mei ^a   Yang, Pi Shan ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Bone morphogenetic protein 2; Nerve growth factor; Periodontal diseases; Regeneration

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; CALCIUM; DRUG CARRIER; NERVE GROWTH FACTOR; PHOSPHATE; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN-2; RECOMBINANT PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL; ARTICLE; BONE REGENERATION; DOG; DRUG COMBINATION; DRUG EFFECT; FEMALE; HUMAN; HYDROGEL; INFLAMMATION; METHODOLOGY; PERIODONTAL DISEASE; PERIODONTICS; PILOT STUDY; SPECTROMETRY; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANIMALS; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEINS; BONE REGENERATION; CALCIUM; DOGS; DRUG CARRIERS; DRUG COMBINATIONS; FEMALE; FURCATION DEFECTS; GUIDED TISSUE REGENERATION, PERIODONTAL; HUMANS; HYDROGEL; INFLAMMATION; NERVE GROWTH FACTOR; PHOSPHATES; PILOT PROJECTS; RECOMBINANT PROTEINS; SPECTROMETRY, X-RAY EMISSION; TRANSFORMING GROWTH FACTOR BETA;

EID: 77956604122     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2010.090655     Document Type: Article

References (49)

1. Devescovi V, Leonardi E, Ciapetti G, Cenni E. Growth factors in bone repair. Chir Organi Mov 2008; 92: 161-168.
2. Sigurdsson TJ, Lee MB, Kubota K, Turek TJ, Wozney JM, Wikesjö UM. Periodontal repair in dogs: Recombinant human bonemorphogenetic protein-2 significantly enhances periodontal regeneration. J Periodontol 1995; 66: 131-138.
3. Kinoshita A, Oda S, Takahashi K, Yokota S, Ishikawa I. Periodontal regeneration by application of recombinant human bone morphogenetic protein-2 to horizontal circumferential defects created by experimental periodontitis in beagle dogs. J Periodontol 1997; 68: 103-109.
4. Cochran DL, Jones AA, Lilly LC, Fiorellini JP, Howell H. Evaluation of recombinant human bone morphogenetic protein-2 in oral applications including the use of endosseous implants: 3-year results of a pilot study in humans. J Periodontol 2000; 71: 1241-1257.
5. Barboza EP, Duarte ME, Geolás L, Sorensen RG, Riedel GE, Wikesjö UM. Ridge augmentation following implantation of recombinant human bone morphogenetic protein-2 in the dog. J Periodontol 2000; 71: 488-496.
6. Carter TG, Brar PS, Tolas A, Beirne OR. Off-label use of recombinant human bone morphogenetic protein-2 (rhBMP-2) for reconstruction of mandibular bone defects in humans. J Oral Maxillofac Surg 2008; 66: 1417-1425.
7. Cheung LK, Zheng LW. Effect of recombinant human bone morphogenetic protein-2 on mandibular distraction at different rates in an experimental model. J Craniofac Surg 2006; 17: 100-108.
8. Wikesjö UM, Xiropaidis AV, Thomson RC, Cook AD, Selvig KA, Hardwick WR. Periodontal repair in dogs: rhBMP-2 significantly enhances bone formation under provisions for guided tissue regeneration. J Clin Periodontol 2003; 30: 705-714.
9. Konttinen Y, Imai S, Suda A. Neuropeptides and the puzzle of bone remodeling. State of the art. Acta Orthop Scand 1996; 67: 632-639.
10. Yamashiro T, Fujiyama K, Fujiyoshi Y, Inaguma N, Takano-Yamamoto T. Inferior alveolar nerve transection inhibits increase in osteoclast appearance during experimental tooth movement. Bone 2000; 26: 663-669.
11. Freehafer AA, Mast WA. Lower extremity fractures in patients with spinal-cord injury. J Bone Joint Surg Am 1965; 47: 683-694.
12. Hardy AG, Dickson JW. Pathological ossification in traumatic paraplegia. J Bone Joint Surg Br 1963; 45: 76-87.
13. Gillespie JA. The nature of the bone changes associated with the nerve injuries and disuse. J Bone Joint Surg Br 1954; 36: 464-473.
14. Madsen JE, Hukkanen M, Aune AK, et al. Fracture healing and callus innervation after peripheral nerve resection in rats. Clin Orthop Relat Res 1998; 351: 230-240.
15. Levi-Montalcini R, Booker B. Excessive growth of the sympathetic ganglia evoked by a protein isolated from mouse salivary glands. Proc Natl Acad Sci U S A 1960; 46: 373-384.
16. Letic-Gavrilovic A, Piattelli A, Abe K. Nerve growth factor beta(NGF beta) delivery via a collagen/hydroxyapatite (Col/HAp) composite and its effects on new bone ingrowth. J Mater Sci Mater Med 2003; 14: 95-102.
17. Grills BL, Schuijers JA, Ward AR. Topical application of nerve growth factor improves fracture healing in rats. J Orthop Res 1997; 15: 235-242.
18. Kurihara H, Shinohara H, Yoshino H, Takeda K, Shiba H. Neurotrophins in cultured cells from periodontal tissues. J Periodontol 2003; 74: 76-84.
19. Xu WP, Mizuno N, Shiba H, et al. Promotion of functioning of human periodontal ligament cells and human endothelial cells by nerve growth factor. J Periodontol 2006; 77: 800-807.
20. Mizuno N, Shiba H, Inui T, et al. Effect of neurotrophin- 4/5 on bone/cementum-related protein expressions and DNA synthesis in cultures of human periodontal ligament cells. J Periodontol 2008; 79: 2182-2189.
21. Minamide A, Yoshida M, Kawakami M, et al. The effects of bone morphogenetic protein and basic fibroblast growth factor on cultured mesenchymal stem cells for spine fusion. Spine 2007; 32: 1067-1071.
22. Takahashi D, Odajima T, Morita M, Kawanami M, Kato H. Formation and resolution of ankylosis under application of recombinant human bone morphogenetic protein-2 (rhBMP-2) to class III furcation defects in cats. J Periodontal Res 2005; 40: 299-305.
23. Austin L, Bower JJ, Kurek JB, Muldoon CM. Controlled release of leukaemia inhibitory factor (LIF) to tissues. Growth Factors 1997; 15: 61-68.
24. Hao X, Silva EA, Månsson-Broberg A, et al. Angiogenic effects of sequential release of VEGF-A165 and PDGF-BB with alginate hydrogels after myocardial infarction. Cardiovasc Res 2007; 75: 178-185.
25. Lu HH, Vo JM, Chin HS, et al. Controlled delivery of platelet-rich plasma-derived growth factors for bone formation. J Biomed Mater Res A 2008; 86: 1128-1136.
26. Suzuki Y, Tanihara M, Suzuki K, Saitou A, Sufan W, Nishimura Y. Alginate hydrogel linked with synthetic oligopeptide derived from BMP-2 allows ectopic osteoinduction in vivo. J Biomed Mater Res 2000; 50: 405-409.
27. Ji AG, Ji P, Song SL, inventors; Shandong University, assignee. In situ forming biodegradable matrix for the treatment of periodontal disease. CN Patent 20091006482.9. October 16, 2009.
28. Park JB, Matsuura M, Han KY, et al. Periodontal regeneration in class III furcation defects of beagle dogs using guided tissue regenerative therapy with platelet-derived growth factor. J Periodontol 1995; 66: 462-477.
29. Araújo MG, Berglundh T, Lindhe J. On the dynamics of periodontal tissue formation in degree III furcation defects. An experimental study in dogs. J Clin Periodontol 1997; 24: 738-746.
30. Berillis P, Emfietzoglou D, Tzaphlidou M. Collagen fibril diameter in relation to bone site and to calcium/phosphorus ratio. Scientific World Journal 2006; 6: 1109-1113.
31. Takayama S, Murakami S, Shimabukuro Y, Kitamura M, Okada A. Periodontal regeneration by FGF-2 (bFGF) in primate models. J Dent Res 2001; 80: 2075-2079.
32. Murano Y, Ota M, Katayama A, Sugito H, Shibukawa Y, Yamada S. Periodontal regeneration following transplantation of proliferating tissue derived from periodontal ligament into class III furcation defects in dogs. Biomed Res 2006; 27: 139-147.
33. Holt SC, Ebersole J, Felton J, Brunsvold M, Kornman KS. Implantation of Bacteroides gingivalis in nonhuman primates initiates progression of periodontitis. Science 1988; 239: 55-57.
34. King GN, King N, Cruchley AT, Wozney JM, Hughes FJ. Recombinant human bone morphogenetic protein- 2 promotes wound healing in rat periodontal fenestration defects. J Dent Res 1997; 76: 1460-1470.
35. Wikesjö UM, Lim WH, Thomson RC, Cook AD, Wozney JM, Hardwick WR. Periodontal repair in dogs: Evaluation of a bioabsorbable space-providing macroporous membrane with recombinant human bone morphogenetic protein-2. J Periodontol 2003; 74: 635-647.
36. Lindsay RM, Harmar AJ. Nerve growth factor regulates expression of neuropeptide genes in adult sensory neurons. Nature 1989; 337: 362-364.
37. Millet I, Vignery A. The neuropeptide calcitonin generelated peptide inhibits TNF-alpha but poorly induces IL-6 production by fetal rat osteoblasts. Cytokine 1997; 9: 999-1007.
38. Vignery A, McCarthy TL. The neuropeptide calcitonin gene-related peptide stimulates insulin-like growth factor I production by primary fetal rat osteoblasts. Bone 1996; 18: 331-335.
39. Zaidi M, Fuller K, Bevis PJ, GainesDas RE, Chambers TJ, MacIntyre I. Calcitonin gene-related peptide inhibits osteoclastic bone resorption: A comparative study. Calcif Tissue Int 1987; 40: 149-154.
40. Nico B, Mangieri D, Benagiano V, Crivellato E, Ribatti D. Nerve growth factor as an angiogenic factor. Microvasc Res 2008; 75: 135-141.
41. Dollé JP, Rezvan A, Allen FD, Lazarovici P, Lelkes PI. Nerve growth factor-induced migration of endothelial cells. J Pharmacol Exp Ther 2005; 315: 1220-1227.
42. Hausman MR, Schaffler MB, Majeska RJ. Prevention of fracture healing in rats by an inhibitor of angiogenesis. Bone 2001; 29: 560-564.
43. Hauge EM, Qvesel D, Eriksen EF, Mosekilde L, Melsen F. Cancellous bone remodeling occurs in specialized compartments lined by cells expressing osteoblastic markers. J Bone Miner Res 2001; 16: 1575-1582.
44. Eghbali-Fatourechi GZ, Lamsam J, Fraser D, Nagel D, Riggs BL, Khosla S. Circulating osteoblast-lineage cells in humans. N Engl J Med 2005; 352: 1959-1966.
45. Asaumi K, Nakanishi T, Asahara H, Inoue H, Takigawa M. Expression of neurotrophins and their receptors (TRK) during fracture healing. Bone 2000; 26: 625-633.
46. Jehan F, Naveilhan P, Neveu I, et al. Regulation of NGF, BDNF and LNGFR gene expression in ROS 17/ 2.8 cells. Mol Cell Endocrinol 1996; 116: 149-156.
47. Tsuboi Y, Nakanishi T, Takano-Yamamoto T, Miyamoto M, Yamashiro T, Takigawa M. Mitogenic effects of neutrophins on a periodontal ligament cell line. J Dent Res 2001; 80: 881-886.
48. Mogi M, Kondo A, Kinpara K, Togari A. Anti-apoptotic action of nerve growth factor in mouse osteoblastic cell line. Life Sci 2000; 67: 1197-1206.
49. Patel ZS, Young S, Tabata Y, Jansen JA, Wong ME, Mikos AG. Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model. Bone 2008; 43: 931-940.